Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen

September 19, 2016 9:51 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) surges higher on FDA approval for eteplirsen

Letter from FDA

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Hot FDA News, Management Changes, Trader Talk

Add Your Comment